Editas, a biotech company, is funding Broad's legal fees [1]. I had thought that another startup was funding Berkeley's side, but am having trouble finding a so

Editas, a biotech company, is funding Broad's legal fees [1]. I had thought that another startup was funding Berkeley's side, but am having trouble finding a source. [1] http://www.sciencemag.org/news/2017/02/how-battle-lines-over-crispr-were-drawn http://www.sciencemag.org/news/2017/02/how-battle-lines-over...